Karim Touijer, MD
Karim Touijer is an Attending Surgeon at Memorial Sloan-Kettering Cancer and Associate Professor of Urology at The Weill Medical College of Cornell University in New York. Dr Touijer is an expert in the use of advanced laparoscopic /robotic surgical techniques to treat patients with genito-urinary cancers (prostate, kidney, bladder, testis and adrenal cancers). He teaches advanced laparoscopic urologic oncology at the European Association of Urology, the American Urological Association Annual Meetings and the European Institute of Telemedicine.
Dr Touijer’s research focuses on the development of innovative minimally invasive techniques such as laparoscopy, robotic assisted surgery, and image guided interventions, the comparison of minimally invasive surgery to conventional open surgery with regards to cancer control and impact on the quality of life, and the implementation of quality outcome metrics to objectively measure and assess surgical performance. His laboratory research focuses on studying lymph node metastases for genitourinary malignancies using cancer targeted nanotechnology probes.
After a fellowship in urologic oncology and advanced laparoscopic oncology at MSKCC, he joined the MSKCC Urology faculty in 2004. Dr Touijer is completing a Master’s in Public Health from the Harvard School of Public Health.
He is board certified by the American Board of Urology, Fellow of the American College of Surgeons and member of the Society of Urologic Oncology, the American Urological Association, the European Association of Urology, the American Society of Clinical Oncology and other national and international societies; additionally he serves on the editorial board and as a reviewer of a number of peer-reviewed urology and cancer journals. Dr Touijer has authored over 100 peer-reviewed journal articles and book chapters. He is the editor of a book chapter on the management of genito-urinary malignancies and a regular visiting professor and guest speaker to numerous meetings and symposia around the world.
Financial relationships
-
Attribution:SelfType of financial relationship:OtherIneligible company:Elucida Oncology
-
Attribution:SelfType of financial relationship:OtherIneligible company:Elucida Oncology
-
Attribution:SelfType of financial relationship:OtherIneligible company:Elucida Oncology